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Abstract 
In a recent article Hontelez et al.1 investigate the prospects for elimination of HIV in South Africa through expanded access to 
antiretroviral therapy (ART) using STDSIM, a micro-simulation model.2 One of the first published models to suggest that 
expanded access to ART could lead to the elimination of HIV, referred to by the authors as ‘the Granich Model’, was 
developed and implemented by the present author.3 The notion that expanded access to ART could lead to the end of the AIDS 
epidemic gave rise to considerable interest and debate and remains contentious. In considering this notion Hontelez et al.1 start 
by stripping down STDSIM to a simple model that is equivalent to the model developed by the present author3 but is a 
stochastic event driven model. Hontelez et al.1 then reintroduce levels of complexity to explore ways in which the model 
structure affects the results. In contrast to our earlier conclusions3 Hontelez et al.1 conclude that universal voluntary 
counselling and testing with immediate ART at 90% coverage should result in the elimination of HIV but would take three 
times longer than predicted by the model developed by the present author.3 Hontelez et al.1 suggest that the current scale-up of 
ART at CD4 cell counts less than 350 cells/μL will lead to elimination of HIV in 30 years. I disagree with both claims and 
believe that their more complex models rely on unwarranted and unsubstantiated assumptions. 
Analysis 
Hontelez et al.1 take an interesting and novel approach to 
examining the extent to which model structure affects the 
predictions of a model. The start from a very detailed 
micro-simulation model, strip it down so that it resembles a 
simple compartmental model, fit this model to the available 
data and then reintroduce various levels of complexity until 
they recover the full micro-simulation model. However, 
their analysis appears to be flawed in important ways and 
these flaws need to be corrected. 
 In their Model A,1 which most closely resembles my 
model3 the steady state prevalence without ART is 15% and 
the incidence is 2% p.a. compared to 15% and 1.4% p.a., 
respectively, for my deterministic model3 (panel A in 
Figure 1). Since, prevalence is approximately equal to 
incidence times the duration of disease of 10 years the 
authors appear to have overestimated the incidence. This is 
a minor consideration and scaling their incidence down by 
35% gives good agreement with my deterministic model3 
before 2005 and after 2013 (panel B in Figure 1). Between 
2005 and 2013 their Model A differs significantly from my 
model (panel B in Figure 1) probably because their Model 
A fails to include the current scale up of ART which has 
now reached about 30% of all prevalent cases.4 If Hontelez 
et al. were to make realistic assumptions in this regard the 
two models would be in close agreement.  
 The Hontelez et al. Model B1 includes age-structure and 
heterogeneity in transmission by stage of infection. This 
increases the time to elimination most probably because 
they assume that in the absence of ART about 16% of 
transmission takes place during early acute/early infection 
which lasts for 3 months. However, available virological 
data suggest that acute infection lasts for not more than two 
weeks and there is no convincing evidence that acute/early 
infection contributes significantly to overall transmission5 
so that this assumption should be revised.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The estimated incidence of HIV in South African adults. A. Blue line: Model A of Hontelez et al.1; Green lines: their 
confidence limits; Red line using my deterministic model.3 B. As in A with the incidence from the Hontelez model scaled 
down by 35%. 
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 The Hontelez et al.1 Model C explicitly introduces 
heterogeneity in sexual behaviour, male circumcision 
coverage, the effect of sexually transmitted infections that 
act as cofactors for HIV transmission, and increases in 
condom use; their model D introduces CD4 cell count 
decline with disease progression and ART coverage at the 
current level of scale up. However, their models C and D 
suggest that the incidence of infection fell by 30% between 
January 1999 and July 1999, a remarkable result. On closer 
inspection this appears to follow from the assumption (their 
Figure S4, Model C1), that condom use increased from 0% 
in January 1999 to 22% six months later, after which it 
remained unchanged. To support this claim they cite two 
studies. The first6 shows a steady increase in the proportion 
of men and women who reported using a condom at last sex 
from 31% in 2002 to 65% in 2008; the second7 shows an 
increase in condom use among women from 15% in 1998 
to 70% in 2009. Neither is consistent with their 
assumptions. One may speculate that they are driven to 
make this assumption because the authors Models C and D 
rely on unrealistic assumptions about heterogeneity in 
sexual behaviour and, to stop the prevalence from 
continuing to rise after the year 2000, they make an 
assumption about the increase in condom use which makes 
little sense. It would be interesting to see the effect on their 
model predictions with realistic assumptions about changes 
in condom use over time. 
 In spite of their unusual and somewhat surprising 
assumptions it is encouraging to see that their model A,1 in 
which the assumptions are soundly based, supports the 
earlier conclusions of our model that regular testing and 
early treatment could lead to the elimination of HIV 
provided one can achieve high rates of testing and high 
levels of adherence. It would be interesting to see how their 
more detailed models change under realistic assumptions, 
especially in relation to the impact of condom use. 
  The challenge now is to mobilize the political will and 
the financial support to make early treatment available to 
all that want it in order to save lives, save money and stop 
AIDS. Waiting to eliminate HIV when we already have the 
scientific evidence and tools to do so is not sound public 
health policy and will result in many unnecessary deaths. 
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